VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,174 | -25.8% | 50,819 | +94.2% | 0.00% | 0.0% |
| Q2 2023 | $641,778 | -2.4% | 26,163 | -7.4% | 0.00% | -25.0% |
| Q1 2023 | $657,378 | -20.1% | 28,250 | -13.1% | 0.00% | -50.0% |
| Q4 2022 | $822,929 | +10.6% | 32,514 | -15.7% | 0.01% | -11.1% |
| Q3 2022 | $744,000 | -23.0% | 38,580 | +3.9% | 0.01% | -10.0% |
| Q2 2022 | $966,000 | -14.4% | 37,144 | -14.7% | 0.01% | 0.0% |
| Q1 2022 | $1,128,000 | -10.5% | 43,535 | +40.3% | 0.01% | 0.0% |
| Q4 2021 | $1,261,000 | -10.2% | 31,036 | -3.9% | 0.01% | -16.7% |
| Q3 2021 | $1,405,000 | +20.4% | 32,286 | +30.8% | 0.01% | +20.0% |
| Q2 2021 | $1,167,000 | -13.8% | 24,691 | -6.5% | 0.01% | 0.0% |
| Q1 2021 | $1,354,000 | -40.8% | 26,406 | -69.1% | 0.01% | +42.9% |
| Q4 2020 | $2,288,000 | – | 85,422 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |